LEVOBUPIVACAINE ALTAN 2,5 mg/mL, solution injectable/pour perfusion — 10 ampoules en verre de 10 mL
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400955060321 -
CIP7
5506032 -
CIS
66497617
What the source publishes
- Holder
- ALTAN PHARMACEUTICALS (ESPAGNE)
- Active ingredients
- CHLORHYDRATE DE LÉVOBUPIVACAÏNE, LÉVOBUPIVACAÏNE
- Form
- solution injectable ou pour perfusion
- Package
- 10 ampoules en verre de 10 mL
- Routes
- infiltration, intrathécale, péribulbaire, péridurale, périneurale
- Administrative status
- authorised
- Supply regime
- réservé à l'usage HOSPITALIER ; liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2018-10-24
- Prescription
- Prescription or restricted
Names this record is found by
- LEVOBUPIVACAINE ALTAN 2,5 mg/mL, solution injectable/pour perfusion — 10 ampoules en verre de 10 mL
- LEVOBUPIVACAINE ALTAN 2,5 mg/mL, solution injectable/pour perfusion
- CHLORHYDRATE DE LÉVOBUPIVACAÏNE
- LÉVOBUPIVACAÏNE
Complete source data
{
"cis": "66497617",
"cip7": "5506032",
"form": "solution injectable ou pour perfusion",
"name": "LEVOBUPIVACAINE ALTAN 2,5 mg/mL, solution injectable/pour perfusion — 10 ampoules en verre de 10 mL",
"cip13": "3400955060321",
"holder": "ALTAN PHARMACEUTICALS (ESPAGNE)",
"routes": [
"infiltration",
"intrathécale",
"péribulbaire",
"péridurale",
"périneurale"
],
"holders": [
"ALTAN PHARMACEUTICALS (ESPAGNE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2018-10-24",
"compositions": [
{
"name": "CHLORHYDRATE DE LÉVOBUPIVACAÏNE",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "22129",
"dosageReference": null,
"pharmaceuticalElement": "solution"
},
{
"name": "LÉVOBUPIVACAÏNE",
"nature": "FT",
"strength": "2,5 mg",
"linkageNumber": "1",
"substanceCode": "23156",
"dosageReference": "1 mL de solution",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "réservé à l'usage HOSPITALIER ; liste I",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "LEVOBUPIVACAINE ALTAN 2,5 mg/mL, solution injectable/pour perfusion",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "10 ampoules en verre de 10 mL",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2019-09-09",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CHLORHYDRATE DE LÉVOBUPIVACAÏNE",
"LÉVOBUPIVACAÏNE"
],
"authorisationProcedure": "Procédure de reconnaissance mutuelle",
"prescriptionConditions": [
"réservé à l'usage HOSPITALIER",
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400955060321"